These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 3504999)
1. [Treatment of hematosis disorders in chronic obstructive bronchitis with almitrine bismesilate]. Raimondi GA Medicina (B Aires); 1987; 47(6):687-8. PubMed ID: 3504999 [No Abstract] [Full Text] [Related]
2. [Treatment of hematosis disorders in chronic obstructive bronchitis with almitrine bismesylate]. González Montaner LJ Medicina (B Aires); 1986; 46(6):739-41. PubMed ID: 3306258 [No Abstract] [Full Text] [Related]
3. [Treatment of chronic obstructive bronchitis with almitrine]. Pilheu JA Medicina (B Aires); 1987; 47(4):442. PubMed ID: 2898724 [No Abstract] [Full Text] [Related]
4. The assessment of almitrine bismesylate in the long-term treatment of chronic obstructive bronchitis. Marsac J Eur J Respir Dis Suppl; 1986; 146():685-93. PubMed ID: 3096766 [No Abstract] [Full Text] [Related]
5. [Value of almitrine dimesylate in the long-term treatment of chronic obstructive bronchitis]. Seignalet C; Miech G Rev Med Interne; 1985; 6 Spec No():21-9. PubMed ID: 3938854 [No Abstract] [Full Text] [Related]
6. [The effect of almitrine dimesylate on pulmonary hemodynamics in healthy subjects and in patients with chronic obstructive bronchitis]. Ansquer JC Prax Klin Pneumol; 1988 Jun; 42 Suppl 1():409-10. PubMed ID: 2902612 [No Abstract] [Full Text] [Related]
7. The acute effect of a single oral dose of 200 mg almitrine on gas exchange in patients with chronic obstructive bronchitis and emphysema, bronchial asthma and lung fibrosis. Magnussen H; Radenbach D; Kiwull-Schöne H Bull Eur Physiopathol Respir; 1987 Aug; 23 Suppl 11():211s-214s. PubMed ID: 3690032 [TBL] [Abstract][Full Text] [Related]
8. [Almitrine in daily practice]. Bourgouin-Karaouni D; Préfaut C Rev Med Interne; 1985; 6 Spec No():15-20. PubMed ID: 3938853 [No Abstract] [Full Text] [Related]
9. [Pulmonary hemodynamic monitoring in chronic respiratory insufficiency treated with almitrine bismesilate for 4 months in a double-blind study]. Bourgouin-Karaouni D; Ramonatxo M; Michel FB; Macabies J; Prefaut C Rev Mal Respir; 1984; 1(4):245-50. PubMed ID: 6505362 [TBL] [Abstract][Full Text] [Related]
10. Long term almitrine bismesylate treatment in patients with chronic bronchitis and emphysema: a multicentre double-blind placebo controlled study. Arnaud F; Bertrand A; Charpin J; Chretien J; Decroix G; Guerrin F; Kalb JC; Lissac J; Michel FB; Morere P Eur J Respir Dis Suppl; 1983; 126():323-36. PubMed ID: 6373343 [No Abstract] [Full Text] [Related]
11. [Almitrine dimesylate (vectarion)--the first representative of a new group of "synergetic" drugs--and its use in pulmonary pathology]. Mihalţan F Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1987; 36(3):209-19. PubMed ID: 2894713 [No Abstract] [Full Text] [Related]
12. Almitrine as a long term treatment for chronic obstructive pulmonary disease. Kauffmann F Bull Eur Physiopathol Respir; 1987; 23(6):667. PubMed ID: 2899444 [No Abstract] [Full Text] [Related]
13. Advances in treatment of chronic obstructive lung disease with almitrine bis-mesylate. Huchon G Postgrad Med J; 1983; 59 Suppl 3():66-7. PubMed ID: 6615607 [TBL] [Abstract][Full Text] [Related]
14. [Originality of the mode of action of almitrine dimesylate]. Tellier P Presse Med; 1984 Oct; 13(34):2083-9. PubMed ID: 6149536 [TBL] [Abstract][Full Text] [Related]
15. [Future prospects concerning the clinical application and clinical pharmacology of almitrine dimesylate]. Duroux P Rev Med Interne; 1985; 6 Spec No():59-60. PubMed ID: 3834560 [No Abstract] [Full Text] [Related]
16. [Vectarian international multicenter study (VIMS) in hypoxemic chronic bronchitis patients treated by the double-blind placebo method for 1 year. Follow-up of the monitoring of 490 patients]. Ansquer JC Rev Med Interne; 1985; 6 Spec No():31-7. PubMed ID: 3914682 [No Abstract] [Full Text] [Related]